Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 189Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Aplenzin

02 3Aplenzin?

PharmaCompass

01

Brand Name : Aplenzin?

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin?

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 98

2019 Revenue in Millions : 83

Growth (%) : 18

blank

02

Brand Name : Aplenzin?

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin?

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 109

2020 Revenue in Millions : 98

Growth (%) : 11

blank

03

Brand Name : Aplenzin?

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin?

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 83

2018 Revenue in Millions : 54

Growth (%) : 54

blank

04

Brand Name : Aplenzin

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 42

2015 Revenue in Millions : 40

Growth (%) : 5

blank

05

Brand Name : Aplenzin

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 31

2016 Revenue in Millions : 42

Growth (%) : -26

blank

06

Brand Name : Aplenzin

Bupropion Hydrobromide

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Aplenzin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bupropion Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 54

2017 Revenue in Millions : 31

Growth (%) : 74%

blank